ARRIVENT BIOPHARMA INC (AVBP) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AVBP • US04272N1028

22.2 USD

-0.3 (-1.33%)

Last: Jan 30, 2026, 09:55 AM

Fundamental Rating

Taking everything into account, AVBP scores 3 out of 10 in our fundamental rating. AVBP was compared to 525 industry peers in the Biotechnology industry. While AVBP has a great health rating, there are worries on its profitability. AVBP has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AVBP has reported negative net income.
In the past year AVBP has reported a negative cash flow from operations.

1.2 Ratios

AVBP has a Return On Assets of -46.36%. This is comparable to the rest of the industry: AVBP outperforms 53.71% of its industry peers.
The Return On Equity of AVBP (-49.64%) is better than 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-46.36%
ROE	-49.64%
ROIC	N/A

ROA(3y)-30.66%

ROA(5y)N/A

ROE(3y)-32.74%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AVBP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, AVBP has more shares outstanding
AVBP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 23.73 indicates that AVBP is not in any danger for bankruptcy at the moment.
AVBP's Altman-Z score of 23.73 is amongst the best of the industry. AVBP outperforms 90.67% of its industry peers.
There is no outstanding debt for AVBP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	23.73

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 14.90 indicates that AVBP has no problem at all paying its short term obligations.
AVBP's Current ratio of 14.90 is amongst the best of the industry. AVBP outperforms 91.81% of its industry peers.
AVBP has a Quick Ratio of 14.90. This indicates that AVBP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 14.90, AVBP belongs to the best of the industry, outperforming 91.81% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	14.9
Quick Ratio	14.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AVBP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.70%.

EPS 1Y (TTM)-61.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-36.07%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

AVBP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.01% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-72.57%

EPS Next 2Y-23.47%

EPS Next 3Y-4.02%

EPS Next 5Y19.01%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVBP. In the last year negative earnings were reported.
Also next year AVBP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.